Anti-tubercular agents. Part 5: Synthesis and biological evaluation of benzothiadiazine 1,1-dioxide based congeners

European Journal of Medicinal Chemistry
2010.0

Abstract

In an effort to discover new and effective chemotherapeutic agents from this laboratory for the treatment of tuberculosis, here in we describe the synthesis and biological evaluation of a series of novel benzothiadiazine 1,1-dioxide (BTD) based congeners by using rifampicin, streptomycin; ciprofloxacin and amphotericin as positive controls. Further, to understand structural requirements for exploring the structure activity relationship of BTDs, cytotoxicity and in vivo study of recently reported potent molecule 4 (MIC = 1 microg/mL) is also discussed.

Knowledge Graph

Similar Paper

Anti-tubercular agents. Part 5: Synthesis and biological evaluation of benzothiadiazine 1,1-dioxide based congeners
European Journal of Medicinal Chemistry 2010.0
Anti-tubercular agents. Part IV: Synthesis and antimycobacterial evaluation of nitroheterocyclic-based 1,2,4-benzothiadiazines
Bioorganic & Medicinal Chemistry Letters 2007.0
Synthesis and structure–activity relationships evaluation of benzothiazinone derivatives as potential anti-tubercular agents
Bioorganic & Medicinal Chemistry Letters 2013.0
Synthesis and antibacterial activity of 2,2'-dithiobis(benzamide) derivatives against Mycobacterium species
Journal of Medicinal Chemistry 1985.0
Synthesis and biological evaluation of new imidazo[2,1-b][1,3,4]thiadiazole-benzimidazole derivatives
European Journal of Medicinal Chemistry 2015.0
Identification of Better Pharmacokinetic Benzothiazinone Derivatives as New Antitubercular Agents
ACS Medicinal Chemistry Letters 2017.0
New class of methyl tetrazole based hybrid of (Z)-5-benzylidene-2-(piperazin-1-yl)thiazol-4(%H)-one as potent antitubercular agents
Bioorganic & Medicinal Chemistry Letters 2014.0
Identification of benzothiazinones containing an oxime functional moiety as new anti-tuberculosis agents
European Journal of Medicinal Chemistry 2019.0
Design, synthesis and antitubercular evaluation of benzothiazinones containing a piperidine moiety
European Journal of Medicinal Chemistry 2018.0
Design, syntheses, and anti-tuberculosis activities of conjugates of piperazino-1,3-benzothiazin-4-ones (pBTZs) with 2,7-dimethylimidazo [1,2-a]pyridine-3-carboxylic acids and 7-phenylacetyl cephalosporins
Bioorganic & Medicinal Chemistry Letters 2016.0